Literature DB >> 9924375

Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis.

K Yokoi1, N Yokoi, S Kinoshita.   

Abstract

AIMS: To assess the integrity of the ocular surface epithelium in patients with atopic dermatitis from the viewpoint of its barrier function.
METHODS: 49 patients with atopic dermatitis with blepharoconjunctivitis (ABC group), 27 age matched patients with seasonal or perennial allergic conjunctivitis (AC group), and 20 volunteers with normal healthy eyes (NH group) were assigned to this study. Ocular surface epithelium barrier function was evaluated by the fluorophotometric method using a slit lamp fluorophotometer. 3 microliters of 0.5% sodium fluorescein was instilled into the conjunctival sac of the right eye and fluorescein uptake (ng/ml) 30 minutes later (20 minutes after eye washing) was measured in the central cornea and the temporal bulbar conjunctiva. Fluorophoto metric measurements performed were analysed in each group and compared between the groups.
RESULTS: The ABC group showed significantly higher fluorescein uptake (mean 28.2 (SEM 3.3) ng/ml) in the cornea than the AC (11.4 (2.2), p = 0.001) and NH groups (9.3 (2.1), p = 0.001). There was no significant difference between the AC and NH groups (p = 0.930). The ABC group also showed significantly higher fluorescein uptake in the bulbar conjunctiva (393.4 (54.0)) than the AC (182.9 (24.6), p = 0.011) and NH groups (169.3 (29.1), p = 0.012). There was also no significant difference in fluorescein uptake between the AC group and the NH group (p = 0.987).
CONCLUSION: This study suggested that ocular surface epithelium barrier function is impaired in patients with atopic dermatitis with blepharoconjunctivitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9924375      PMCID: PMC1722655          DOI: 10.1136/bjo.82.7.797

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  Atopic keratoconjunctivitis.

Authors:  M J HOGAN
Journal:  Trans Am Ophthalmol Soc       Date:  1952

2.  Atopic keratoconjunctivitis.

Authors:  M J HOGAN
Journal:  Am J Ophthalmol       Date:  1953-07       Impact factor: 5.258

3.  [A new slit-lamp fluorophotometer for the clinical evaluation of corneal epithelial barrier function].

Authors:  N Yokoi; S Kinoshita; K Akiyama
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1994-07

4.  Clinical features of atopic keratoconjunctivitis.

Authors:  S J Tuft; D M Kemeny; J K Dart; R J Buckley
Journal:  Ophthalmology       Date:  1991-02       Impact factor: 12.079

5.  Eosinophil granule major basic protein inhibition of corneal epithelial wound healing.

Authors:  S D Trocmé; G J Gleich; G M Kephart; J D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-06       Impact factor: 4.799

6.  Conjunctival epithelial cell hypermitosis and goblet cell hyperplasia in atopic keratoconjunctivitis.

Authors:  M I Roat; M Ohji; L E Hunt; R A Thoft
Journal:  Am J Ophthalmol       Date:  1993-10-15       Impact factor: 5.258

7.  Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis.

Authors:  S D Trocme; G M Kephart; M R Allansmith; W M Bourne; G J Gleich
Journal:  Am J Ophthalmol       Date:  1989-07-15       Impact factor: 5.258

8.  Eosinophil granule major basic protein and Charcot-Leyden crystal protein in human tears.

Authors:  I J Udell; G J Gleich; M R Allansmith; S J Ackerman; M B Abelson
Journal:  Am J Ophthalmol       Date:  1981-12       Impact factor: 5.258

9.  Atopic keratoconjunctivitis.

Authors:  C S Foster; M Calonge
Journal:  Ophthalmology       Date:  1990-08       Impact factor: 12.079

Review 10.  Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy.

Authors:  M B Abelson; K Schaefer
Journal:  Surv Ophthalmol       Date:  1993 Jul-Aug       Impact factor: 6.048

View more
  7 in total

Review 1.  [Diagnosis and treatment of eyelid eczema. An interdisciplinary challenge].

Authors:  A Wollenberg; K Kerschenlohr; T Pavicic; E M Messmer
Journal:  Hautarzt       Date:  2004-07       Impact factor: 0.751

Review 2.  The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases.

Authors:  Flavio Mantelli; Jerome Mauris; Pablo Argüeso
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-10

3.  Corneal permeability changes in dry eye disease: an observational study.

Authors:  Kenji Fujitani; Neha Gadaria; Kyu-In Lee; Brendan Barry; Penny Asbell
Journal:  BMC Ophthalmol       Date:  2016-05-13       Impact factor: 2.209

Review 4.  Conjunctivitis in patients with atopic dermatitis treated with dupilumab.

Authors:  Sandra Ferreira; Tiago Torres
Journal:  Drugs Context       Date:  2020-05-04

5.  Conjunctivitis in dupilumab clinical trials.

Authors:  B Akinlade; E Guttman-Yassky; M de Bruin-Weller; E L Simpson; A Blauvelt; M J Cork; E Prens; P Asbell; E Akpek; J Corren; C Bachert; I Hirano; J Weyne; A Korotzer; Z Chen; T Hultsch; X Zhu; J D Davis; L Mannent; J D Hamilton; A Teper; H Staudinger; E Rizova; G Pirozzi; N M H Graham; B Shumel; M Ardeleanu; A Wollenberg
Journal:  Br J Dermatol       Date:  2019-05-07       Impact factor: 9.302

Review 6.  Why Chain Length of Hyaluronan in Eye Drops Matters.

Authors:  Wolfgang G K Müller-Lierheim
Journal:  Diagnostics (Basel)       Date:  2020-07-23

Review 7.  Epithelial barrier dysfunction in ocular allergy.

Authors:  Neera Singh; Yolanda Diebold; Srikant K Sahu; Andrea Leonardi
Journal:  Allergy       Date:  2021-11-28       Impact factor: 14.710

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.